These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6634455)

  • 1. [Growth hormone secretion in patients with various types of diabetes mellitus and in healthy persons after L-dopa stimulation].
    Muszyński J
    Pol Arch Med Wewn; 1983; 69(4-5):341-50. PubMed ID: 6634455
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of hyperglycemia on the growth hormone response to L-dopa in diabetic subjects.
    Barbarino A; De Marinis L; Martino F
    J Endocrinol Invest; 1978 Jul; 1(3):259-61. PubMed ID: 756876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levodopa and somatotropic hormone in diabetes].
    Carducci Artenisio A; Ragonese F; Martelli G; Forte F; Campisi R; Consolo F
    Boll Soc Ital Biol Sper; 1978 Oct; 54(20):1972-7. PubMed ID: 753286
    [No Abstract]   [Full Text] [Related]  

  • 4. [A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
    Shimoda S; Takemura Y; Ieiri T; Kasai K; Kikuchi T
    Nihon Naibunpi Gakkai Zasshi; 1975 Jan; 51(1):9-17. PubMed ID: 1171032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dihydroergotoxine-ethanesulphonate (Redergam) on the basal and with 3-(3,4-dihydroxyphenyl)-L-alanine (L-DOPA) stimulated somatotrophic secretion of diabetic patients.
    Dobrew D; Zonew I; Milanow S
    Ther Hung; 1977; 25(4):145-9. PubMed ID: 605413
    [No Abstract]   [Full Text] [Related]  

  • 6. [Growth hormone secretion in insulin test in various forms of diabetes].
    Sieradzki J; Szybiński Z
    Pol Arch Med Wewn; 1975 Jun; 53(6):579-86. PubMed ID: 1138248
    [No Abstract]   [Full Text] [Related]  

  • 7. [Somatotropic function of the hypophysis in patients with diabetes mellitus].
    Kostiuk EP
    Vrach Delo; 1985 Feb; (2):52-5. PubMed ID: 3992987
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopaminergic stimulation of HGH in diabetes mellitus and in obesity.
    Gragnoli G; Palazzuoli V; Favilli R; Tanganelli I; Migliarese G
    Acta Diabetol Lat; 1977; 14(3-4):137-43. PubMed ID: 605744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB; Scott CL; Modebe O; Bethune JE
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Endokrynol Pol; 1992; 43(3):344-8. PubMed ID: 1345575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of growth hormone in the insulin test in various forms of diabetes.
    Sieradzki J; Szybiński Z
    Pol Med Sci Hist Bull (1973); 1976; 15(2):185-90. PubMed ID: 959043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does gonadotropin-releasing hormone administration affect serum growth hormone levels in poorly controlled insulin-dependent and non-insulin-dependent diabetes mellitus?
    Gürlek A; Yordam N; Telatar F
    Isr J Med Sci; 1995 Nov; 31(11):685-9. PubMed ID: 7591703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Somatotropic, prolactotropic and thyrotropic functions of the hypophysis in patients with diabetes mellitus].
    Perelygina AA; Golikova AA
    Ter Arkh; 1986; 58(10):91-4. PubMed ID: 3798358
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stimulation of growth hormone secretion by the anterior pituitary gland using L-DOPA compared to growth hormone secretion following argine, insulin and sleep].
    Lucke C; Höffken B; Morgner KD
    Verh Dtsch Ges Inn Med; 1974; 80():1328-30. PubMed ID: 4454413
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationale for inhibition of growth hormone secretion in the management of the diabetic patient.
    Gerich JE
    Scand J Gastroenterol Suppl; 1986; 119():154-7. PubMed ID: 2876500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished growth hormone secretion in blind males after L-dopa stimulation.
    Fatranská M; Jurcovicová J; Németh S; Vigas M
    Endocrinol Exp; 1988 Dec; 22(4):243-8. PubMed ID: 3243205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of L-dopa induced growth hormone release in normal and diabetic subjects by glucose administration.
    Vigas M; Klimes I; Jurcovicova J; Kolesar P; Repcekova-Jezova D
    Diabete Metab; 1977 Dec; 3(4):257-8. PubMed ID: 598566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A; Vacca U; Pirro R; Cerone G
    Clin Ter; 1975 Aug; 74(3):265-70. PubMed ID: 1227747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of L-dopa and propranolol administration on GH secretion in essential obesity in women].
    Cabezas-Cerrato J; Mur AL; Aranguren LV; Vila T; Fernández-Cruz A
    Rev Clin Esp; 1975 Jun; 137(6):497-502. PubMed ID: 1162133
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone reserve in diabetes mellitus.
    Winkler G; Gerò L; Kollin E; Halmos T; Grósz A; Karádi I; Simonyi E; Gefferth G; Vargha P
    Acta Med Hung; 1987; 44(2-3):269-87. PubMed ID: 3684449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.